Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABROCITINIB vs ACEMETACIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ABROCITINIB vs ACEMETACIN: Safety Overview

Metric ABROCITINIB ACEMETACIN
Total FAERS Reports 3,170 182
Deaths Reported 57 7
Death Rate 1.8% 3.8%
Hospitalizations 329 139
Average Patient Age 48.5 yrs 49.1 yrs
% Female Patients 53.9% 57.8%
FDA Approval Date Jan 14, 2022 N/A
Manufacturer U.S. Pharmaceuticals N/A
Route ORAL N/A
Marketing Status Prescription N/A